ACADIA PHARMA LIMITED
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (55/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
Corporate timeline (32 events)Click to expand
- 2025-09-18📄accounts-with-accounts-type-dormantaccounts · AA
- 2024-10-24📄accounts-with-accounts-type-dormantaccounts · AA
- 2024-09-11📄capital-allotment-sharescapital · SH01
- 2024-05-01📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2024-05-01📄appoint-person-director-company-with-name-dateofficers · AP01
- 2024-05-01📄appoint-person-secretary-company-with-name-dateofficers · AP03
- 2024-05-01📄termination-director-company-with-name-termination-dateofficers · TM01
- 2024-04-30➕RHODES, Jennifer appointedsecretary
- 2024-04-30➕RHODES, Jennifer appointeddirector
- 2024-04-30➖KIM, Austin resignedsecretary
- 2024-04-30➖KIM, Austin resigneddirector
- 2024-01-12📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-08-31📄second-filing-of-director-appointment-with-nameofficers · RP04AP01
- 2023-08-24📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2023-08-02📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2023-08-02📄withdrawal-of-a-person-with-significant-control-statementpersons-with-significant-control · PSC09
- 2023-08-02📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-08-02📄administrative-restoration-companyrestoration · RT01
- 2023-04-11📄gazette-dissolved-compulsorygazette · GAZ2
- 2023-01-03📄gazette-notice-compulsorygazette · GAZ1
- 2022-11-02📄gazette-filings-brought-up-to-dategazette · DISS40
- 2022-11-01📄gazette-notice-compulsorygazette · GAZ1
- 2022-01-28📄change-person-secretary-company-with-change-dateofficers · CH03
- 2022-01-28📄change-person-director-company-with-change-dateofficers · CH01
- 2022-01-10📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-10-01➕KIM, Austin appointedsecretary
- 2019-10-01➕KIM, Austin appointeddirector
- 2018-08-01➖BAITY, Glenn resignedsecretary
- 2018-08-01➖BAITY, Glenn resigneddirector
- 2015-08-13🏢Company incorporatedAs ACADIA PHARMA LIMITED
- 2015-08-13➕BAITY, Glenn appointedsecretary
- 2015-08-13➕BAITY, Glenn appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanGroup structure
Acadia Pharmaceuticals Inc. is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Acadia Pharmaceuticals Inc. Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · WA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A.H DENT LTD→ 14013749 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| A&J SPHYNX LIMITED→ 11023777 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ACUPUNCTURE & HERBS LIMITED→ 04611979 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| ADVANCED SKIN SERVICES LTD→ 16866810 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AFK ENTERPRISE LIMITED→ 15476419 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE CONCERN MID MERSEY→ 02625647 · est 1991 · no financials extracted | — | — | — | — | 34y | — | — |
| AHMED MEDICAL CONSULTANCY SERVICES LTD→ 09411105 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| AHR CARE LTD→ 12190496 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AIDAPT BATHROOMS LIMITED→ 02464054 · est 1990 · no financials extracted | — | — | — | — | 36y | — | — |
| AJ HEALTH SOLUTION LTD→ 15705835 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AJ SMILES LTD→ 14142832 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AJC MEDICAL SERVICES LTD→ 15444181 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 4 resigned)
Click a director name to see their full track record across all companies.